Citations are updated once a week. Recently added citations may not appear.
The suggestion is based on each study and bacteria having different weight based on a multitude of factors. For example, how severe a shift is seen.
Context | Citation |
---|---|
Increases Bacteroides xylanisolvens - : Crataegus {Hawthorn} |
👶
Procyanidins from hawthorn (Crataegus pinnatifida) alleviate lipid metabolism disorder via inhibiting insulin resistance and oxidative stress, normalizing the gut microbiota structure and intestinal barrier, and further suppressing hepatic inflammation and lipid accumulation. Food & function (Food Funct ) Vol: 13 Issue 14 Pages: 7901-7917 Pub: 2022 Jul 18 Epub: 2022 Jul 18 Authors Han X , Zhao W , Zhou Q , Chen H , Yuan J , Xiaofu Z , Zhang Z , Publication |
Increases Bacteroides xylanisolvens - : Crataegus {Hawthorn} |
👶
Crataegus pinnatifida polysaccharide alleviates colitis via modulation of gut microbiota and SCFAs metabolism. International journal of biological macromolecules (Int J Biol Macromol ) Vol: 181 Issue Pages: 357-368 Pub: 2021 Jun 30 Epub: 2021 Mar 24 Authors Guo C , Wang Y , Zhang S , Zhang X , Du Z , Li M , Ding K , Publication |
Decreases Bacteroides xylanisolvens - : Crataegus {Hawthorn} |
👶
Characterization of procyanidin extracts from hawthorn (Crataegus pinnatifida) in human colorectal adenocarcinoma cell line Caco-2, simulated Digestion, and fermentation identified unique and novel prebiotic properties. Food research international (Ottawa, Ont.) (Food Res Int ) Vol: 165 Issue Pages: 112393 Pub: 2023 Mar Epub: 2022 Dec 28 Authors Han X , Zhou Q , Gao Z , Bianca Xu G , Chen H , Chitrakar B , Sun Y , Zhao W , Lin X , Zhou K , Zhang Z , Publication |
0 π | π’ 0 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]